Last update :
03/05/2024
References   References 3647  
Type : Manufacturer

Research teams :
Authors :
Title : Trastuzumab (Herceptin® 600 mg for subcutaneous injection) - Summary of Product Characteristics
Reference : Roche 2019

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionTrastuzumab Anticancer drug
Stability in solutions Polypropylen Syringe None 120 mg/ml 2-8°C Protect from light
48 Hour
Stability in solutions Polypropylen Syringe None 120 mg/ml <30°C Light
6 Hour

  Mentions Légales